PL402470A1 - Enhancing composition flexibility of the blood vessels of the eye - Google Patents

Enhancing composition flexibility of the blood vessels of the eye

Info

Publication number
PL402470A1
PL402470A1 PL402470A PL40247013A PL402470A1 PL 402470 A1 PL402470 A1 PL 402470A1 PL 402470 A PL402470 A PL 402470A PL 40247013 A PL40247013 A PL 40247013A PL 402470 A1 PL402470 A1 PL 402470A1
Authority
PL
Poland
Prior art keywords
amount
weight
blueberry
vitamin
eye
Prior art date
Application number
PL402470A
Other languages
Polish (pl)
Other versions
PL220788B1 (en
Inventor
Magdalena Adamska
Original Assignee
Przedsiębiorstwo Farmaceutyczne Lek-Am Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Przedsiębiorstwo Farmaceutyczne Lek-Am Spółka Z Ograniczoną Odpowiedzialnością filed Critical Przedsiębiorstwo Farmaceutyczne Lek-Am Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL402470A priority Critical patent/PL220788B1/en
Publication of PL402470A1 publication Critical patent/PL402470A1/en
Publication of PL220788B1 publication Critical patent/PL220788B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Kompozycja do podawania doustnego zawiera ekstrakt z owoców borówki czernicy w ilości 90-98% wag., rutynę w ilości 1-5% wag., trokserutynę w ilości 1-5% wag., a ponadto zawiera co najmniej jeden składnik wybrany z grupy zawierającej: witaminę C, w ilości 5-15% wag., witaminę E w ilości 1-5% wag., sól cynku w ilości 1-5% wag. w przeliczeniu na cynk, witaminę B6 w ilości 0,1-2% wag. i witaminę B2 w ilości 0,1-2% wag., gdzie udział składników dodatkowych jest podany w stosunku do łącznej masy ekstraktu z borówki czernicy, rutyny i trokserutyny, przy czym zawartość antocyjanów w ekstrakcie z owoców borówki czernicy zawiera się w przedziale 20-30%, a dzienna dawka kompozycji zawiera od 99 do 600 mg antocyjanów.The composition for oral administration contains blueberry fruit extract in an amount of 90-98% by weight, routine in an amount of 1-5% by weight, troxerutin in an amount of 1-5% by weight, and furthermore contains at least one ingredient selected from the group consisting of : vitamin C in an amount of 5-15% by weight, vitamin E in an amount of 1-5% by weight, zinc salt in an amount of 1-5% by weight calculated as zinc, vitamin B6 in an amount of 0.1-2 wt. and vitamin B2 in an amount of 0.1-2% by weight, where the proportion of additional ingredients is given in relation to the total weight of blueberry, blueberry, routine and troxerutin extract, the anthocyanin content of blueberry blueberry extract being in the range of 20 30%, and the daily dose of the composition contains from 99 to 600 mg of anthocyanins.

PL402470A 2013-01-18 2013-01-18 Enhancing composition flexibility of the blood vessels of the eye PL220788B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL402470A PL220788B1 (en) 2013-01-18 2013-01-18 Enhancing composition flexibility of the blood vessels of the eye

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL402470A PL220788B1 (en) 2013-01-18 2013-01-18 Enhancing composition flexibility of the blood vessels of the eye

Publications (2)

Publication Number Publication Date
PL402470A1 true PL402470A1 (en) 2014-07-21
PL220788B1 PL220788B1 (en) 2016-01-29

Family

ID=51179311

Family Applications (1)

Application Number Title Priority Date Filing Date
PL402470A PL220788B1 (en) 2013-01-18 2013-01-18 Enhancing composition flexibility of the blood vessels of the eye

Country Status (1)

Country Link
PL (1) PL220788B1 (en)

Also Published As

Publication number Publication date
PL220788B1 (en) 2016-01-29

Similar Documents

Publication Publication Date Title
CY1120628T1 (en) FLAVONID BASED COMPOSITION FOR PHARMACEUTICAL, NUTRITIONAL OR COSMETIC USE THAT HAVE ENHANCED ANTIOXIDANT ACTION
AR098882A1 (en) DENTAL COMPOSITION THAT INCLUDES ZINC OXIDE AND ZINC CITRATE
AR052851A1 (en) OXIDATION RESISTANT DENTIFRIC COMPOSITIONS
MX2011012547A (en) Green tea extracts of improved bioavailability.
BR112015014480A2 (en) stable compositions containing metal ions
MX2019008650A (en) Stable and liposoluble active ingredient composition, microcapsule, and preparation method and application thereof.
BR112014003640A2 (en) weight loss methods and ketogenic compositions
BR112012019997A2 (en) oral care compositions
MX357554B (en) Aloe vera sprout concentrate or extract having superior skin cell growth promotion, antioxidant, and anti-allergy effects.
ECSP13012799A (en) USE OF NUTRITIONAL COMPOSITIONS THAT INCLUDE LACTOFERRINS TO IMPROVE RESISTANCE TO DISEASES AND CONDITIONS
BR112012026346A2 (en) Innovative formulations of active ingredients (s) of vegetable origin or their synthetic analogs or extracts thereof including vegetable lacitin
UA75461U (en) Medicine for the prevention of dental diseases
GB201310235D0 (en) Nutraceutical and pharmaceutical composition
BR112015027991A2 (en) petroselinic acid or combination of active ingredients, comprising at least petroselinic acid to promote weight loss and / or weight maintenance
MX2014014579A (en) O/w-emulsion-type topical pharmaceutical compositions containing a retinoid.
BR112013026933A2 (en) use of a combination of at least one carotenoid
WO2014006635A3 (en) Solid oral compositions of silodosin
PL402470A1 (en) Enhancing composition flexibility of the blood vessels of the eye
MY170724A (en) Use of certain trioxygenated benzene derivatives in body fat management
GEP20196957B (en) Crystalline forms of s-acetyl glutathione, their reparations and uses in pharmaceutical and nutraceutical formulations
RU2014146562A (en) ALPHA-LIPOIC ACID AND RACNOCIOLE COMPOSITION FOR THE TREATMENT OF NEUROPATHIES
MX2015007347A (en) Gel compositions.
PL426617A1 (en) Dietary supplement
PL405875A1 (en) Dietary supplement
PL408434A1 (en) Dietary food product used in nephrolithiasis